1% tenofovir gel

GPTKB entity

Statements (18)
Predicate Object
gptkbp:instanceOf microbicide
gptkbp:activeIngredient tenofovir
gptkbp:administeredBy vaginal application
gptkbp:concentration 1%
gptkbp:developer gptkb:Gilead_Sciences
gptkbp:effect reduced HIV acquisition in clinical trials
reduced HSV-2 acquisition in clinical trials
gptkbp:form topical gel
https://www.w3.org/2000/01/rdf-schema#label 1% tenofovir gel
gptkbp:intendedUse HIV prevention
HSV-2 prevention
gptkbp:mechanismOfAction reverse transcriptase inhibition
gptkbp:routeOfAdministration topical
gptkbp:status investigational drug
gptkbp:studiedIn gptkb:CAPRISA_004_trial
gptkbp:studiedPopulation gptkb:women
gptkbp:bfsParent gptkb:CAPRISA_004_microbicide_trial
gptkbp:bfsLayer 7